Pa, I., R, N., R, N., Ing, B. and K, T. 2018. DIFFERENCE IN BLOOD FUNCTION TOXICITY BETWEEN STADIUM IIB-IIIB SQUAMOUS CELL CERVICAL CANCER PATIENTS WITH PACLITAXEL CISPLATIN AND PACLITAXEL CARBOPLATIN CHEMOTHERAPY AT SANGLAH HOSPITAL, DENPASAR. Asian Journal of Pharmaceutical and Clinical Research. 11, 1 (Jan. 2018), 224–227. DOI:https://doi.org/10.22159/ajpcr.2018.v11i1.22125.